157 related articles for article (PubMed ID: 20144195)
1. Decreased NPC1L1 expression in the liver from Chinese female gallstone patients.
Cui W; Jiang ZY; Cai Q; Zhang RY; Wu WZ; Wang JC; Fei J; Zhang SD; Han TQ
Lipids Health Dis; 2010 Feb; 9():17. PubMed ID: 20144195
[TBL] [Abstract][Full Text] [Related]
2. Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients.
Jiang ZY; Jiang CY; Wang L; Wang JC; Zhang SD; Einarsson C; Eriksson M; Han TQ; Parini P; Eggertsen G
Biochem Biophys Res Commun; 2009 Jan; 379(1):49-54. PubMed ID: 19071091
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients.
Jiang ZY; Parini P; Eggertsen G; Davis MA; Hu H; Suo GJ; Zhang SD; Rudel LL; Han TQ; Einarsson C
J Lipid Res; 2008 Feb; 49(2):464-72. PubMed ID: 18007013
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Niemann-Pick C1-like 1.
Pramfalk C; Jiang ZY; Parini P
Curr Opin Lipidol; 2011 Jun; 22(3):225-30. PubMed ID: 21494140
[TBL] [Abstract][Full Text] [Related]
5. Combination of curcumin and piperine prevents formation of gallstones in C57BL6 mice fed on lithogenic diet: whether NPC1L1/SREBP2 participates in this process?
Li Y; Li M; Wu S; Tian Y
Lipids Health Dis; 2015 Sep; 14():100. PubMed ID: 26335572
[TBL] [Abstract][Full Text] [Related]
6. The NPC1L1 Polymorphism 1679C>G Is Associated with Gallstone Disease in Chinese Patients.
Wu J; Cui W; Cai Q; Fei J; Zhang SD; Han TQ; Hu H; Jiang ZY
PLoS One; 2016; 11(1):e0147562. PubMed ID: 26800364
[TBL] [Abstract][Full Text] [Related]
7. Ezetimibe prevents cholesterol gallstone formation in mice.
Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
[TBL] [Abstract][Full Text] [Related]
8. HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver.
Pramfalk C; Jiang ZY; Cai Q; Hu H; Zhang SD; Han TQ; Eriksson M; Parini P
J Lipid Res; 2010 Jun; 51(6):1354-62. PubMed ID: 20460578
[TBL] [Abstract][Full Text] [Related]
9. Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients.
Herrera J; Amigo L; Husche C; Benítez C; Zanlungo S; Lütjohann D; Miquel JF; Nervi F
Lipids Health Dis; 2009 Dec; 8():53. PubMed ID: 19995447
[TBL] [Abstract][Full Text] [Related]
10. Dietary diosgenin transcriptionally down-regulated intestinal NPC1L1 expression to prevent cholesterol gallstone formation in mice.
Shen W; Shao W; Wang Q; Wang B; Zhao G; Gu A; Jiang Z; Hu H
J Biomed Sci; 2023 Jun; 30(1):44. PubMed ID: 37370162
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet.
Han T; Lv Y; Wang S; Hu T; Hong H; Fu Z
Lipids Health Dis; 2019 Dec; 18(1):218. PubMed ID: 31829191
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of sterol transporters in children with future gallstones.
Nissinen MJ; Pitkänen N; Simonen P; Gylling H; Viikari J; Raitakari O; Lehtimäki T; Juonala M; Pakarinen MP
Dig Liver Dis; 2018 Sep; 50(9):954-960. PubMed ID: 29764733
[TBL] [Abstract][Full Text] [Related]
14. Common variant p.D19H of the hepatobiliary sterol transporter ABCG8 increases the risk of gallstones in children.
Krawczyk M; Niewiadomska O; Jankowska I; Jankowski K; Więckowski S; Lebensztejn D; Więcek S; Gozdowska J; Kułaga Z; Weber SN; Lütjohann D; Lammert F; Socha P
Liver Int; 2022 Jul; 42(7):1585-1592. PubMed ID: 35129276
[TBL] [Abstract][Full Text] [Related]
15. Effect of hepatic NPC1L1 on cholesterol gallstone disease and its mechanism.
Mo P; Chen H; Jiang X; Hu F; Zhang F; Shan G; Chen W; Li S; Xu G
Heliyon; 2023 May; 9(5):e15757. PubMed ID: 37159680
[TBL] [Abstract][Full Text] [Related]
16. Altered Bile Transporter Expression and Cholesterol Metabolism in Children With Cholesterol and Pigment Gallstones.
Koivusalo A; Mutanen A; Nissinen M; Gylling H; Pakarinen M
J Pediatr Gastroenterol Nutr; 2019 Aug; 69(2):138-144. PubMed ID: 31169656
[TBL] [Abstract][Full Text] [Related]
17. Impaired regulation of sterol regulatory element binding protein 2 in cholesterol gallstone-susceptible mice.
Xu G; Müller O; Stange EF; Fuchs M
Biochim Biophys Acta; 2004 Apr; 1688(3):274-9. PubMed ID: 15062879
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of Niemann-Pick C1 protein protects against diet-induced gallstone formation in mice.
Morales MG; Amigo L; Balboa E; Acuña M; Castro J; Molina H; Miquel JF; Nervi F; Rigotti A; Zanlungo S
Liver Int; 2010 Jul; 30(6):887-97. PubMed ID: 20408952
[TBL] [Abstract][Full Text] [Related]
19. Sitosterol reduces messenger RNA and protein expression levels of Niemann-Pick C1-like 1 in FHs 74 Int cells.
Jesch ED; Seo JM; Carr TP; Lee JY
Nutr Res; 2009 Dec; 29(12):859-66. PubMed ID: 19963159
[TBL] [Abstract][Full Text] [Related]
20. Intestinal and hepatic Niemann-Pick C1L1 proteins: future therapeutic targets for cholesterol gallstones disease?
Castro-Torres IG; De la O-Arciniega M; Bravo-Duarte GA; Gallegos-Estudillo J; Domínguez-Ortíz MÁ; Martínez-Vázquez M
Eur J Pharmacol; 2014 Apr; 728():77-81. PubMed ID: 24525336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
